secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLUS THERAPEUTICS, INC. (PSTV)
CIK:        0001095981
Form:       8-K
Filed at:   2025-06-20T23:59:59+00:00
Accession:  0001193125-25-143665
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud

Plus Therapeutics enters $50M common stock purchase agreement with Lincoln Park Capital
--------------------------------------------------------------------------------

- Plus Therapeutics signed a purchase agreement with Lincoln Park Capital for up to $50 million of common stock over 36 months.
- Lincoln Park commits to buy up to 300,000 shares per regular purchase (up to 500,000 at higher prices) at 97% of market price.
- The company will pay a $500,000 initial commitment fee in cash or stock, plus $500,000 after reaching $25 million in sales.
- Proceeds will fund working capital and a $17.3 million make-whole repayment to March 2025 warrant holders.
- Issuance beyond 10,194,593 shares requires shareholder approval unless average sale price exceeds $0.3576.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1095981/000119312525143665/0001193125-25-143665-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1095981/000119312525143665/d925162d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-143665

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer